The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production
Open accessAbstract
The generation of vaccines for highly pathogenic avian influenza viruses, including those of the H5N1 subtype, relies on reverse genetics, which allows the production of influenza viruses from cloned cDNA. In the future, reverse genetics will likely be the method of choice for the generation of conventional influenza vaccine strains because gene reassortment by more traditional methods is cumbersome. Established systems for the artificial generation of influenza A viruses require transfection of cells with the eight to 12 plasmids that provide the eight influenza viral RNAs as well as the polymerase and nucleoproteins of the virus. However, cell lines appropriate for human vaccine production (e.g., Vero cells) cannot be transfected with high efficiencies. To overcome these problems, we established a reverse genetics system in which the eight RNA polymerase I transcription cassettes for viral RNA synthesis are combined on one plasmid. Similarly, two cassettes encoding the hemagglutinin and neuraminidase segments and six cassettes encoding the remaining proteins were combined. We also combined three RNA polymerase II transcription cassettes for the expression of the polymerase subunits. By combining these cassettes, we reduced the number of plasmids required for virus generation significantly and produced influenza A virus in Vero cells with higher efficiency than with the traditional 12 plasmid system. This new system is thus suitable for influenza virus vaccine production and may be applicable to other reverse genetics systems that rely on the introduction of several plasmids into eukaryotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Re-emergence of fatal human influenza A subtype H5N1 disease
Peiris, J., Yu, W., Leung, C., Cheung, C., Ng, W., Nicholls, J., Ng, T., Chan, K., Lai, S., Lim, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15595-5 · Cited by 812
Cited by
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
Traditional and New Influenza Vaccines
Wong, S.-S., & Webby, R. J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-12 · Cited by 372
Steel, J., Lowen, A. C., Pena, L., Angel, M., Solórzano, A., Albrecht, R., Perez, D. R., García-Sastre, A., & Palese, P. (2009) · Journal of Virology · doi:10.1128/jvi.01920-08 · Cited by 258
Baas, T., Baskin, C. R., Diamond, D. L., García-Sastre, A., Bielefeldt-Ohmann, H., Tumpey, T. M., Thomas, M. J., Carter, V. S., Teal, T. H., Van Hoeven, N., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00851-06 · Cited by 121
Phosphorylation controls RNA binding and transcription by the influenza virus polymerase
Dawson, A. R., Wilson, G. M., Freiberger, E. C., Mondal, A., Coon, J. J., & Mehle, A. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008841 · Cited by 32
Metadata
- Authors
- Neumann, G., Fujii, K., Kino, Y., & Kawaoka, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-11-02
- Volume
- 102
- Issue
- 46
- Pages
- 16825-16829
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2023534522
- Cited by
- 170
- References
- 1
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. https://app.cochat.ai/papers/10.1073/pnas.0505587102
- The paper
- Neumann, G., Fujii, K., Kino, Y., & Kawaoka, Y. (2005). An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0505587102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.